vs
Side-by-side financial comparison of IMAX CORP (IMAX) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.
OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $125.2M, roughly 1.2× IMAX CORP). IMAX CORP runs the higher net margin — 0.5% vs -21.1%, a 21.6% gap on every dollar of revenue. On growth, IMAX CORP posted the faster year-over-year revenue change (35.1% vs -19.2%). IMAX CORP produced more free cash flow last quarter ($28.0M vs $-28.6M). Over the past eight quarters, IMAX CORP's revenue compounded faster (25.8% CAGR vs -7.5%).
IMAX Corporation is a Canadian production theatre company which designs and manufactures IMAX cameras and projection systems as well as performing film development, production, post-production and distribution to IMAX-affiliated theatres worldwide. Founded in Montreal in 1967, it has headquarters in the Toronto area, and operations in New York City and Los Angeles.
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
IMAX vs OPK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $125.2M | $148.5M |
| Net Profit | $637.0K | $-31.3M |
| Gross Margin | 57.6% | 43.1% |
| Operating Margin | 19.3% | -25.8% |
| Net Margin | 0.5% | -21.1% |
| Revenue YoY | 35.1% | -19.2% |
| Net Profit YoY | -88.0% | -322.8% |
| EPS (diluted) | $0.02 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $125.2M | $148.5M | ||
| Q3 25 | $106.7M | $151.7M | ||
| Q2 25 | $91.7M | $156.8M | ||
| Q1 25 | $86.7M | $150.0M | ||
| Q4 24 | $92.7M | $183.6M | ||
| Q3 24 | $91.5M | $173.6M | ||
| Q2 24 | $89.0M | $182.2M | ||
| Q1 24 | $79.1M | $173.7M |
| Q4 25 | $637.0K | $-31.3M | ||
| Q3 25 | $20.7M | $21.6M | ||
| Q2 25 | $11.3M | $-148.4M | ||
| Q1 25 | $2.3M | $-67.6M | ||
| Q4 24 | $5.3M | $14.0M | ||
| Q3 24 | $13.9M | $24.9M | ||
| Q2 24 | $3.6M | $-10.3M | ||
| Q1 24 | $3.3M | $-81.8M |
| Q4 25 | 57.6% | 43.1% | ||
| Q3 25 | 63.1% | 32.9% | ||
| Q2 25 | 58.5% | 31.5% | ||
| Q1 25 | 61.4% | 28.4% | ||
| Q4 24 | 52.2% | 46.1% | ||
| Q3 24 | 55.8% | 23.1% | ||
| Q2 24 | 49.4% | 28.4% | ||
| Q1 24 | 59.3% | 24.2% |
| Q4 25 | 19.3% | -25.8% | ||
| Q3 25 | 27.2% | 31.7% | ||
| Q2 25 | 15.6% | -38.3% | ||
| Q1 25 | 19.3% | -44.8% | ||
| Q4 24 | 10.3% | -18.0% | ||
| Q3 24 | 21.2% | 8.2% | ||
| Q2 24 | 3.2% | -33.9% | ||
| Q1 24 | 15.3% | -41.2% |
| Q4 25 | 0.5% | -21.1% | ||
| Q3 25 | 19.4% | 14.3% | ||
| Q2 25 | 12.3% | -94.7% | ||
| Q1 25 | 2.7% | -45.1% | ||
| Q4 24 | 5.7% | 7.6% | ||
| Q3 24 | 15.2% | 14.3% | ||
| Q2 24 | 4.0% | -5.7% | ||
| Q1 24 | 4.1% | -47.1% |
| Q4 25 | $0.02 | $-0.04 | ||
| Q3 25 | $0.37 | $0.03 | ||
| Q2 25 | $0.20 | $-0.19 | ||
| Q1 25 | $0.04 | $-0.10 | ||
| Q4 24 | $0.09 | $0.02 | ||
| Q3 24 | $0.26 | $0.03 | ||
| Q2 24 | $0.07 | $-0.01 | ||
| Q1 24 | $0.06 | $-0.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $151.2M | $364.4M |
| Total DebtLower is stronger | — | $344.0M |
| Stockholders' EquityBook value | $337.9M | $1.3B |
| Total Assets | $894.0M | $1.9B |
| Debt / EquityLower = less leverage | — | 0.27× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $151.2M | $364.4M | ||
| Q3 25 | $143.1M | $412.0M | ||
| Q2 25 | $109.3M | $267.3M | ||
| Q1 25 | $97.1M | $428.8M | ||
| Q4 24 | $100.6M | $426.6M | ||
| Q3 24 | $104.5M | $400.1M | ||
| Q2 24 | $91.6M | $40.6M | ||
| Q1 24 | $81.0M | $75.6M |
| Q4 25 | — | $344.0M | ||
| Q3 25 | — | $344.2M | ||
| Q2 25 | — | $343.3M | ||
| Q1 25 | — | $439.2M | ||
| Q4 24 | — | $437.2M | ||
| Q3 24 | — | $441.0M | ||
| Q2 24 | — | $201.9M | ||
| Q1 24 | — | $350.1M |
| Q4 25 | $337.9M | $1.3B | ||
| Q3 25 | $349.5M | $1.3B | ||
| Q2 25 | $320.4M | $1.3B | ||
| Q1 25 | $299.5M | $1.3B | ||
| Q4 24 | $299.5M | $1.4B | ||
| Q3 24 | $289.4M | $1.4B | ||
| Q2 24 | $267.2M | $1.4B | ||
| Q1 24 | $258.8M | $1.3B |
| Q4 25 | $894.0M | $1.9B | ||
| Q3 25 | $889.6M | $2.0B | ||
| Q2 25 | $868.6M | $2.0B | ||
| Q1 25 | $848.3M | $2.1B | ||
| Q4 24 | $830.4M | $2.2B | ||
| Q3 24 | $847.6M | $2.3B | ||
| Q2 24 | $827.4M | $2.0B | ||
| Q1 24 | $824.1M | $2.0B |
| Q4 25 | — | 0.27× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.33× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.31× | ||
| Q2 24 | — | 0.14× | ||
| Q1 24 | — | 0.28× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.4M | $-25.9M |
| Free Cash FlowOCF − Capex | $28.0M | $-28.6M |
| FCF MarginFCF / Revenue | 22.3% | -19.3% |
| Capex IntensityCapex / Revenue | 1.1% | 1.8% |
| Cash ConversionOCF / Net Profit | 46.11× | — |
| TTM Free Cash FlowTrailing 4 quarters | $118.9M | $-190.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.4M | $-25.9M | ||
| Q3 25 | $67.5M | $-34.6M | ||
| Q2 25 | $23.2M | $-83.4M | ||
| Q1 25 | $7.0M | $-34.6M | ||
| Q4 24 | $11.5M | $-44.4M | ||
| Q3 24 | $35.3M | $-77.1M | ||
| Q2 24 | $35.0M | $-26.4M | ||
| Q1 24 | $-11.0M | $-35.6M |
| Q4 25 | $28.0M | $-28.6M | ||
| Q3 25 | $64.8M | $-37.8M | ||
| Q2 25 | $20.9M | $-86.7M | ||
| Q1 25 | $5.3M | $-37.7M | ||
| Q4 24 | $6.9M | $-49.8M | ||
| Q3 24 | $34.2M | $-85.0M | ||
| Q2 24 | $33.5M | $-33.7M | ||
| Q1 24 | $-12.1M | $-40.0M |
| Q4 25 | 22.3% | -19.3% | ||
| Q3 25 | 60.7% | -24.9% | ||
| Q2 25 | 22.8% | -55.3% | ||
| Q1 25 | 6.1% | -25.2% | ||
| Q4 24 | 7.4% | -27.1% | ||
| Q3 24 | 37.3% | -49.0% | ||
| Q2 24 | 37.6% | -18.5% | ||
| Q1 24 | -15.3% | -23.0% |
| Q4 25 | 1.1% | 1.8% | ||
| Q3 25 | 2.6% | 2.1% | ||
| Q2 25 | 2.6% | 2.1% | ||
| Q1 25 | 1.9% | 2.1% | ||
| Q4 24 | 5.0% | 2.9% | ||
| Q3 24 | 1.2% | 4.6% | ||
| Q2 24 | 1.8% | 4.0% | ||
| Q1 24 | 1.4% | 2.6% |
| Q4 25 | 46.11× | — | ||
| Q3 25 | 3.27× | -1.60× | ||
| Q2 25 | 2.06× | — | ||
| Q1 25 | 2.99× | — | ||
| Q4 24 | 2.16× | -3.17× | ||
| Q3 24 | 2.54× | -3.10× | ||
| Q2 24 | 9.78× | — | ||
| Q1 24 | -3.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMAX
| Technology Sales | $46.6M | 37% |
| Image Enhancement And Maintenance Services | $38.1M | 30% |
| Joint Revenue Sharing Arrangement | $20.4M | 16% |
| Maintenance | $16.3M | 13% |
| Finance Income | $2.8M | 2% |
| Other Content Solutions | $1.6M | 1% |
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
